Q: Can you tell me about ejection fractions? My wife’s heart doctor recently told us that her heart is weak, and she has a low ejection fraction. He did not discuss this much, but he has put her on ...
A Tale of Two Citizens: A State Attorney General and a Hematologist Facilitate Translation of Research Into US Food and Drug Administration Actions—A SONAR Report The median age was 71 years, and 54% ...
Early and intensive guideline-directed medical therapy shows the recovery of heart function within 3 months among patients ...
Dear Doctor K: My husband has heart failure. His doctor often uses the term "ejection fraction." Can you explain what this means? Dear Reader: With heart failure, the heart is still pumping it's just ...
DEAR DOCTOR K: My husband has heart failure. His doctor often uses the term “ejection fraction.” Can you explain what this means? DEAR READER: Before I explain what an ejection fraction is, let’s say ...
Heart failure with preserved ejection fraction (HFpEF) is a type of heart failure that affects the left side of the heart. It occurs when the lower left chamber of the heart, called the left ventricle ...
Valeeta Gibson thought it was "kind of strange" when her husband, Carl, received a letter from the Tampa Bay Heart Institute at Northside Hospital, asking whether he knew his "ejection fraction'' ...
Among patients with heart failure with preserved ejection fraction (HFpEF), lower versus higher ranges of EF signal fundamentally different morphologies and hemodynamic responses, which may have ...
Clinical Trials Arena on MSN
MSD’s Phase II Cadence trial of Winrevair achieves primary goal
Cadence is a placebo-controlled, randomised, double-blind trial assessing Winrevair’s safety and efficacy in CpcPH patients.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results